Press Releases

PMC press releases highlight the significance of the Coalition’s activities in education, advocacy, and evidence development.

Study of Six Provider Institutions Suggests Systemic Commitment to Personalized Medicine Improves Quality of Care Provided to Patients

September 24, 2024

A new peer-reviewed study shows that institutions with higher scores on a multi-factorial assessment of personalized medicine integration are more consistently matching cancer patients with genetically guided treatment options.

September 24 , 2024

Study of Six Provider Institutions Suggests Systemic Commitment to Personalized Medicine Improves Quality of Care Provided to Patients

July 8 , 2024

PMC President Edward Abrahams to Retire Dec. 31, 2024

The Personalized Medicine Coalition announces today that its founding president, Edward Abrahams, plans to retire on December 31, 2024, after 20 years of service to the organization.

March 13 , 2024

Underrepresented Community Leaders Outline How to Improve Diversity and Inclusion in Biomedical Research

PMC engaged more than 60 leaders, including 38 from historically underrepresented communities

February 29 , 2024

In 2023, Personalized Medicines Topped One Third of New Drug Approvals for Fourth Year in a Row

Pace of personalized rare disease treatment approvals more than doubled, from six in 2022 to 16 in 2023

January 17 , 2024

Reflecting Membership Across Health Care Spectrum, PMC Board of Directors Elects Five New Members From Multiple Business Sectors

Reflecting its membership from across the health care spectrum, PMC recently elected five new board members from multiple sectors of the health care ecosystem to help guide the future development of its educational, advocacy, and research programs.

October 18 , 2023

Personalized Medicine Coalition Welcomes Rep. John Moolenaar (R-MI-02) as Co-Chair of Congressional Personalized Medicine Caucus

The Personalized Medicine Coalition (PMC) is pleased today to welcome congressman John Moolenaar (R-MI-02) as a new co-chair of the Congressional Personalized Medicine Caucus.

June 14 , 2023

PMC Board of Directors Shows Cross-Sector Convening Capacity With Election of New Members From Diagnostics, Pharmaceutical, and Payer Sectors

Demonstrating PMC's ability to convene executive leaders from across the health care spectrum, PMC today announced that its board of directors has voted to elect three new board members.

February 23 , 2023

Personalized Medicines Topped 25 Percent of New Drug Approvals for Eighth Year in a Row in 2022, Accounting for 34 Percent of New Molecular Entities Approved

Personalized Medicine at FDA: The Scope & Significance of Progress in 2022 Documents Pharmaceutical Industry Shift Away from One-Size-Fits-All Drugs

November 1 , 2022

JCO Precision Oncology Report Shows Diagnostic Testing-Informed Treatment Strategies Benefitting Only 36 Percent of Lung Cancer Patients With Potentially Actionable Biomarkers

Clinical Practice Gaps Likely Inhibiting Impact of Personalized Medicine

April 11 , 2022

Bolstering Personalized Medicine's Evidence Base, New Economic Modeling Study Shows Broad-Based Genomic Profiling Cost-Effective for Diagnosing Infants With Suspected Rare Genetic Diseases

Cost-Effectiveness Estimates for Infants Less Than a Year Old and Children Under Age 18 May Inform Provider and Payer Practices

February 22 , 2022

Seventh Annual Edition of PMC’s Personalized Medicine at FDA Finds Field Expanding Across Disease States, Shows Personalized Medicines Accounting for More Than a Third of Newly Approved Drugs

PMC President: Newly Approved Treatments and Diagnostic Tools ‘Leave No Question’ About Emergence of Era of Personalized Medicine, Presenting Both Opportunities and Challenges for Patients and Health Systems

February 17 , 2022

Emphasizing Opportunities to Advance Personalized Medicine, PMC White Paper on Future of Health Data Calls for Policy Solutions in Key Areas

Representatives From Change Healthcare, Flatiron Health, and Tempus to Discuss Significance of Paper’s Recommendations at 12:00 p.m. ET

Press Releases

FeaTured News

Study of Six Provider Institutions Suggests Systemic Commitment to Personalized Medicine Improves Quality of Care Provided to Patients